| David Wayne Henderson, RPH | |
|
1408 Golden Springs Rd, Anniston, AL 36207-6924 | |
| (256) 831-9960 | |
| (256) 831-8398 |
| Full Name | David Wayne Henderson |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 1408 Golden Springs Rd, Anniston, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720196645 | NPI | - | NPPES |
| 10834 | Other | AL | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10834 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| David Wayne Henderson, RPH 53 Heritage Way, Oxford, AL 36203-3944 Ph: (256) 835-6695 | David Wayne Henderson, RPH 1408 Golden Springs Rd, Anniston, AL 36207-6924 Ph: (256) 831-9960 |
News Archive
The Premier healthcare alliance today announced that new SEEDS agreements for disposable labor and delivery products have been awarded to Kerma Medical Products Inc. of Suffolk, Va. and Genesis Medical Products Inc. of Wrentham, Mass.
EDDA Technology announced today that the number of clinical cases evaluated for pre- and post- operative assessment using IQQA-Liver in hospitals has exceeded 1000 examinations, since the first commercial system installation in Q2 2009. EDDA's IQQA-Liver, now marketed worldwide, is a comprehensive workflow solution supporting modern multidisciplinary liver imaging evaluation and management.
AB SCIEX, a global leader in life science analytical technologies, today announced the launch of the Eksigent ekspert nanoLC 400 system.
Predictive Biosciences today announced that the Company will be presenting results on the development of a real-time multiplexed PCR assay for detection of FGFR3 mutations in urine and tissue at the American Society of Clinical Oncology (ASCO) 2011 Genitourinary Cancers Symposium being held February 17 - 19 in Orlando, Florida. Results will also focus on the application of the assay which is currently being used in Predictive's first commercial molecular grading product, the CertNDxTM Molecular Grading Assay.
With 40 percent of all heart attacks and related cardiovascular problems occurring in people who have low levels of so-called "good" cholesterol, researchers have long sought medications to increase the amount of this type of cholesterol in the body's circulation.
› Verified 8 days ago
Dr. David Adam Kelly, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1401 S Quintard Ave, Anniston, AL 36201 Phone: 256-237-0759 Fax: 256-237-3023 | |
Dr. Molly Victoria Gaines, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1404 Golden Springs Rd, Anniston, AL 36207 Phone: 256-832-0046 Fax: 256-832-0335 | |
Mr. Patrick Lane Knight, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Noble St, Anniston, AL 36201 Phone: 256-236-2271 Fax: 256-236-1859 | |
Mr. Maurice D Grider, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1311 Lakeshore Dr, Anniston, AL 36207 Phone: 256-238-0344 | |
Nancy Schewanick, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 800 Noble St, Anniston, AL 36201 Phone: 256-236-2271 Fax: 256-236-1859 | |
Marcus Compton, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1801 Quintard Ave, Anniston, AL 36201 Phone: 256-831-6116 | |
Michelle Friday, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2413 Highway 431 North, Anniston, AL 36206 Phone: 256-820-6901 |